Connie Stephens
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Mace L. Rothenberg (4 shared papers)Daniel D. Von Hoff (3 shared papers)Malcolm J. Moore (2 shared papers)Peter G. Tarassoff (2 shared papers)Howard A. Burris (2 shared papers)John Sahl Andersen (2 shared papers)Ryan Nelson (2 shared papers)F. Andrew Dorr (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (1 paper)Investigational New Drugs (1 paper)Cancer Biology & Therapy (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Connie Stephens
9 papers receiving 4.8k citations
Connie Stephens's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 3.3k
- Cancer Research 888
- Pulmonary and Respiratory Medicine 646
- Epidemiology 555
- Biotechnology 152
Countries citing papers authored by Connie Stephens
This map shows the geographic impact of Connie Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connie Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connie Stephens more than expected).
Fields of papers citing papers by Connie Stephens
This network shows the impact of papers produced by Connie Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connie Stephens. The network helps show where Connie Stephens may publish in the future.
Co-authors
The 25 scholars most cited alongside Connie Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Hit paper breakdown → | 1997 | 4651 |
| 2 | 2005 | 129 | |
| 3 | 1998 | 67 | |
| 4 | 2014 | 26 | |
| 5 | 2023 | 13 | |
| 6 | 2003 | 13 | |
| 7 | 1997 | 11 | |
| 8 | 2023 | 5 | |
| 9 | 2006 | 3 |
About Connie Stephens
Connie Stephens is a scholar working on Oncology, Genetics, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 9 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Prostate Cancer Treatment and Research (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper), Mesenchymal stem cell research (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (888 citations), Pulmonary and Respiratory Medicine (646 citations), Epidemiology (555 citations) and Biotechnology (152 citations). Connie Stephens has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Mace L. Rothenberg, Daniel D. Von Hoff, Malcolm J. Moore, Peter G. Tarassoff, Howard A. Burris, John Sahl Andersen, Ryan Nelson, F. Andrew Dorr, Russell K. Portenoy and M. Christine Cripps. Their work appears in journals such as Journal of Clinical Oncology, Blood, Investigational New Drugs, Cancer Biology & Therapy and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.